Amplitude Surgical SA (1AU.F)
- Previous Close
2.8200 - Open
2.7800 - Bid 2.8400 x 100000
- Ask 3.0000 x 100000
- Day's Range
2.7800 - 2.7800 - 52 Week Range
2.6200 - 3.5400 - Volume
500 - Avg. Volume
8 - Market Cap (intraday)
140.125M - Beta (5Y Monthly) 0.53
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0600 - Earnings Date Mar 20, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Amplitude Surgical SA develops and markets products for orthopedic surgery. The company provides a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities primarily for foot and ankle surgery. It also offers AMPLIVISION, a computer-assisted surgical system; the i.M.A.G.E., a single-use made-to-measure instrument system; and E.T.O.I.L.E, a technology platform for anterior approaches resulting in less-invasive surgery. In addition, the company provides instruments for fitting related accessories. It sells its products through a network of distributors and agents in approximately 30 countries. The company serves patients, surgeons, and healthcare facilities. Amplitude Surgical SA was founded in 1997 and is headquartered in Valence, France. As of January 21, 2021, Amplitude Surgical SA operates as a subsidiary of PAI Partners.
www.amplitude-surgical.comRecent News: 1AU.F
Performance Overview: 1AU.F
Trailing total returns as of 5/31/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1AU.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1AU.F
Valuation Measures
Market Cap
140.13M
Enterprise Value
221.64M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.28
Price/Book (mrq)
1.41
Enterprise Value/Revenue
2.13
Enterprise Value/EBITDA
10.75
Financial Highlights
Profitability and Income Statement
Profit Margin
41.54%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
104.1M
Net Income Avi to Common (ttm)
-2.95M
Diluted EPS (ttm)
-0.0600
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--